BridgeBio Pharma (BBIO) Current Taxes (2024 - 2025)
BridgeBio Pharma's (BBIO) quarterly Current Taxes came in at $2.1 million in Q2 2025, up 82.13% quarter-over-quarter from $1.2 million in Q4 2024.
BridgeBio Pharma (BBIO) Current Taxes (2024 - 2025) Analysis & Trends
BridgeBio Pharma has disclosed Current Taxes across 2 years of filings, most recently posting $2.1 million for Q2 2025.
- Current Taxes for Q2 2025 came in at $2.1 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was $2.1 million (changed N/A YoY), and the FY2024 annual result was $1.2 million, changed N/A from the prior year.
- Current Taxes came in at $2.1 million for Q2 2025 at BridgeBio Pharma, up from $1.2 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $2.1 million in Q2 2025 to a low of $1.2 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 10,460.56 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | BridgeBio Pharma | 12.90 Bn | 11.97 Bn | 184.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 2.10 Mn |
| Dec 31, 2024 | 1.15 Mn |